torsdag 27. august 2020

Inside the company at the forefront of China's push to develop a coronavirus vaccine

Inside the white, sterile walls of a new building on the southern outskirts of Beijing, two employees donning masks and rubber gloves are busy pipetting a clear, colorless liquid into rows of small vials.
In some areas, the interior fit-out is still underway. Outside, construction vehicles are digging up dirt. The 215,000 square feet (20,000 square meter) production plant was built in recent months specifically for producing a Covid-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech.

CoronaVac, the vaccine candidate from Sinovac, is part of China's push to be at the forefront of rolling out immunizations against the deadly novel coronavirus -- and to demonstrate its scientific prowess.